IRIDEX Corporation (NASDAQ:IRIX) traded today at a new 52-week high of $6.50. So far today approximately 1.2 million shares have been exchanged, as compared to an average 30-day volume of 634,000 shares.
Based on a current price of $6.50, IRIDEX Corporation is currently 6.5% above its average consensus analyst price target of $6.08.
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include lasers, laser delivery devices, glaucoma devices, retinal surgical instruments, veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment that is ophthalmology. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific.
In the past 52 weeks, shares of IRIDEX Corporation have traded between a low of $1.22 and a high of $6.50 and is now at $6.50, which is 433% above that low price.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer